Bumper Offer - Urjas oil Just @ Rs. 1
Levera 250 Tablet (10), a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Epilepsy. The alternative uses of Levera 250 Tablet (10) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Levera 250 Tablet (10). Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Levera 250 Tablet (10) include Fatigue, Headache, Drowsiness. Besides the aforementioned side effects, there are other adverse effects of Levera 250 Tablet (10) as well, which are listed below. These side effects of Levera 250 Tablet (10) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Levera 250 Tablet (10)'s effect is Moderate during pregnancy and Mild for lactating mothers. Further, the section on Levera 250 Tablet (10) related warnings talks about Levera 250 Tablet (10)'s effects on the liver, heart and kidney.
Other contraindications of Levera 250 Tablet (10) have been discussed in the sections ahead.
Besides this, Levera 250 Tablet (10) may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Levera 250 Tablet (10), it is important to know that it is not safe while driving, and is not habit-forming.
Levera 250 Tablet (10) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Levera 250 Tablet (10) safe for pregnant women?
Levera can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Levera right away. Take your doctor's advice before taking it again.
Is the use of Levera 250 Tablet (10) safe during breastfeeding?
Breastfeeding women can take Levera as it bears very minor side effects for them.
What is the effect of Levera 250 Tablet (10) on the Kidneys?
Levera rarely harms the kidneys.
What is the effect of Levera 250 Tablet (10) on the Liver?
Side effects of Levera rarely affect the liver.
What is the effect of Levera 250 Tablet (10) on the Heart?
There are no any side effects of Levera for the heart.
Levera 250 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levera 250 Tablet (10) unless your doctor advises you to do so -
Is this Levera 250 Tablet (10) habit forming or addictive?
No, there is no any evidence that Levera 250 Tablet (10) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Levera 250 Tablet (10) as you may feel sleepy.
Is it safe?
Yes, Levera 250 Tablet (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Levera 250 Tablet (10) works for mental disorders.
Interaction between Food and Levera 250 Tablet (10)
Taking Levera 250 Tablet (10) with food does not harm your health.
Interaction between Alcohol and Levera 250 Tablet (10)
Consumption of alcohol and Levera 250 Tablet (10) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
